Company Filing History:
Years Active: 2013
Title: Oliver Robin Barker: Innovator in Hsp90 Inhibitors
Introduction
Oliver Robin Barker is a notable inventor based in Oxfordshire, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target Hsp90, a heat shock protein involved in various diseases.
Latest Patents
Barker holds a patent for "Quinazolin-oxime derivatives as Hsp90 inhibitors." This patent describes compounds of general formula (I), including their stereoisomers, tautomers, pharmaceutically acceptable salts, or prodrugs. These compounds are designed to treat diseases and conditions mediated by excessive or inappropriate Hsp90 activity, such as cancers, viral infections, and inflammatory diseases.
Career Highlights
Oliver Robin Barker has been instrumental in advancing therapeutic options through his innovative research. His work has led to the development of a patent that holds promise for treating serious health conditions, showcasing his expertise in the field.
Collaborations
Barker has collaborated with notable colleagues, including Stephen Martin Courtney and Mark Whittaker, contributing to a dynamic research environment that fosters innovation.
Conclusion
Oliver Robin Barker's contributions to the field of medicinal chemistry, particularly through his patent on Hsp90 inhibitors, highlight his role as a significant inventor in the industry. His work continues to pave the way for new therapeutic approaches to challenging diseases.